The global Injectable Anthelmintic Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Injectable Anthelmintic Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Injectable Anthelmintic Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Injectable Anthelmintic Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Injectable Anthelmintic Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Injectable Anthelmintic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Injectable Anthelmintic Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Injectable Anthelmintic Drugs Market Report

Report Metric	Details
Report Name	Injectable Anthelmintic Drugs Market
CAGR	5%
Segment by Type	Benzimidazoles Piperazine Imidazothiazole Spiroindoles Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies Veterinary Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck, Boehringer Ingelheim International
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Injectable Anthelmintic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anthelmintic Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injectable Anthelmintic Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Injectable Anthelmintic Drugs Market report?

Ans: The main players in the Injectable Anthelmintic Drugs Market are Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck, Boehringer Ingelheim International

What are the Application segmentation covered in the Injectable Anthelmintic Drugs Market report?

Ans: The Applications covered in the Injectable Anthelmintic Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, Others

What are the Type segmentation covered in the Injectable Anthelmintic Drugs Market report?

Ans: The Types covered in the Injectable Anthelmintic Drugs Market report are Benzimidazoles, Piperazine, Imidazothiazole, Spiroindoles, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Benzimidazoles

1.2.3 Piperazine

1.2.4 Imidazothiazole

1.2.5 Spiroindoles

1.2.6 Others

1.3 Market by Application

1.3.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.3.5 Veterinary Pharmacies

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Injectable Anthelmintic Drugs Market Perspective (2019-2030)

2.2 Global Injectable Anthelmintic Drugs Growth Trends by Region

2.2.1 Injectable Anthelmintic Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Injectable Anthelmintic Drugs Historic Market Size by Region (2019-2024)

2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Region (2025-2030)

2.3 Injectable Anthelmintic Drugs Market Dynamics

2.3.1 Injectable Anthelmintic Drugs Industry Trends

2.3.2 Injectable Anthelmintic Drugs Market Drivers

2.3.3 Injectable Anthelmintic Drugs Market Challenges

2.3.4 Injectable Anthelmintic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Injectable Anthelmintic Drugs by Players

3.1.1 Global Injectable Anthelmintic Drugs Revenue by Players (2019-2024)

3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Injectable Anthelmintic Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio

3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2023

3.5 Global Key Players of Injectable Anthelmintic Drugs Head office and Area Served

3.6 Global Key Players of Injectable Anthelmintic Drugs, Product and Application

3.7 Global Key Players of Injectable Anthelmintic Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Anthelmintic Drugs Breakdown Data by Type

4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2019-2024)

4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2025-2030)

5 Injectable Anthelmintic Drugs Breakdown Data by Application

5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2019-2024)

5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Injectable Anthelmintic Drugs Market Size (2019-2030)

6.2 North America Injectable Anthelmintic Drugs Market Size by Type

6.2.1 North America Injectable Anthelmintic Drugs Market Size by Type (2019-2024)

6.2.2 North America Injectable Anthelmintic Drugs Market Size by Type (2025-2030)

6.2.3 North America Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

6.3 North America Injectable Anthelmintic Drugs Market Size by Application

6.3.1 North America Injectable Anthelmintic Drugs Market Size by Application (2019-2024)

6.3.2 North America Injectable Anthelmintic Drugs Market Size by Application (2025-2030)

6.3.3 North America Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

6.4 North America Injectable Anthelmintic Drugs Market Size by Country

6.4.1 North America Injectable Anthelmintic Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Injectable Anthelmintic Drugs Market Size by Country (2019-2024)

6.4.3 North America Injectable Anthelmintic Drugs Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Injectable Anthelmintic Drugs Market Size (2019-2030)

7.2 Europe Injectable Anthelmintic Drugs Market Size by Type

7.2.1 Europe Injectable Anthelmintic Drugs Market Size by Type (2019-2024)

7.2.2 Europe Injectable Anthelmintic Drugs Market Size by Type (2025-2030)

7.2.3 Europe Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

7.3 Europe Injectable Anthelmintic Drugs Market Size by Application

7.3.1 Europe Injectable Anthelmintic Drugs Market Size by Application (2019-2024)

7.3.2 Europe Injectable Anthelmintic Drugs Market Size by Application (2025-2030)

7.3.3 Europe Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

7.4 Europe Injectable Anthelmintic Drugs Market Size by Country

7.4.1 Europe Injectable Anthelmintic Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Injectable Anthelmintic Drugs Market Size by Country (2019-2024)

7.4.3 Europe Injectable Anthelmintic Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Injectable Anthelmintic Drugs Market Size (2019-2030)

8.2 China Injectable Anthelmintic Drugs Market Size by Type

8.2.1 China Injectable Anthelmintic Drugs Market Size by Type (2019-2024)

8.2.2 China Injectable Anthelmintic Drugs Market Size by Type (2025-2030)

8.2.3 China Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

8.3 China Injectable Anthelmintic Drugs Market Size by Application

8.3.1 China Injectable Anthelmintic Drugs Market Size by Application (2019-2024)

8.3.2 China Injectable Anthelmintic Drugs Market Size by Application (2025-2030)

8.3.3 China Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Injectable Anthelmintic Drugs Market Size (2019-2030)

9.2 Asia Injectable Anthelmintic Drugs Market Size by Type

9.2.1 Asia Injectable Anthelmintic Drugs Market Size by Type (2019-2024)

9.2.2 Asia Injectable Anthelmintic Drugs Market Size by Type (2025-2030)

9.2.3 Asia Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

9.3 Asia Injectable Anthelmintic Drugs Market Size by Application

9.3.1 Asia Injectable Anthelmintic Drugs Market Size by Application (2019-2024)

9.3.2 Asia Injectable Anthelmintic Drugs Market Size by Application (2025-2030)

9.3.3 Asia Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

9.4 Asia Injectable Anthelmintic Drugs Market Size by Region

9.4.1 Asia Injectable Anthelmintic Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Injectable Anthelmintic Drugs Market Size by Region (2019-2024)

9.4.3 Asia Injectable Anthelmintic Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Injectable Anthelmintic Drugs Introduction

11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2019-2024)

11.1.5 Novartis Recent Developments

11.2 Cipla

11.2.1 Cipla Company Details

11.2.2 Cipla Business Overview

11.2.3 Cipla Injectable Anthelmintic Drugs Introduction

11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2019-2024)

11.2.5 Cipla Recent Developments

11.3 Sun Pharmaceutical Industries

11.3.1 Sun Pharmaceutical Industries Company Details

11.3.2 Sun Pharmaceutical Industries Business Overview

11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction

11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2019-2024)

11.3.5 Sun Pharmaceutical Industries Recent Developments

11.4 Amneal Pharmaceuticals

11.4.1 Amneal Pharmaceuticals Company Details

11.4.2 Amneal Pharmaceuticals Business Overview

11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction

11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2019-2024)

11.4.5 Amneal Pharmaceuticals Recent Developments

11.5 Zoetis

11.5.1 Zoetis Company Details

11.5.2 Zoetis Business Overview

11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction

11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2019-2024)

11.5.5 Zoetis Recent Developments

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Company Details

11.6.2 GlaxoSmithKline Business Overview

11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction

11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2019-2024)

11.6.5 GlaxoSmithKline Recent Developments

11.7 Bayer

11.7.1 Bayer Company Details

11.7.2 Bayer Business Overview

11.7.3 Bayer Injectable Anthelmintic Drugs Introduction

11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2019-2024)

11.7.5 Bayer Recent Developments

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Injectable Anthelmintic Drugs Introduction

11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2019-2024)

11.8.5 Merck Recent Developments

11.9 Boehringer Ingelheim International

11.9.1 Boehringer Ingelheim International Company Details

11.9.2 Boehringer Ingelheim International Business Overview

11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction

11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2019-2024)

11.9.5 Boehringer Ingelheim International Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Novartis

Cipla Ltd

Sun Pharmaceutical Industries

Amneal Pharmaceuticals

Boehringer Ingelheim International

List of Tables

Table 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Benzimidazoles

Table 3. Key Players of Piperazine

Table 4. Key Players of Imidazothiazole

Table 5. Key Players of Spiroindoles

Table 6. Key Players of Others

Table 7. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Injectable Anthelmintic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Injectable Anthelmintic Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Injectable Anthelmintic Drugs Market Share by Region (2019-2024)

Table 11. Global Injectable Anthelmintic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Injectable Anthelmintic Drugs Market Share by Region (2025-2030)

Table 13. Injectable Anthelmintic Drugs Market Trends

Table 14. Injectable Anthelmintic Drugs Market Drivers

Table 15. Injectable Anthelmintic Drugs Market Challenges

Table 16. Injectable Anthelmintic Drugs Market Restraints

Table 17. Global Injectable Anthelmintic Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Injectable Anthelmintic Drugs Revenue Share by Players (2019-2024)

Table 19. Global Top Injectable Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2023)

Table 20. Global Injectable Anthelmintic Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Injectable Anthelmintic Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Injectable Anthelmintic Drugs, Headquarters and Area Served

Table 23. Global Key Players of Injectable Anthelmintic Drugs, Product and Application

Table 24. Global Key Players of Injectable Anthelmintic Drugs, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Injectable Anthelmintic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2019-2024)

Table 28. Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2025-2030)

Table 30. Global Injectable Anthelmintic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Injectable Anthelmintic Drugs Revenue Share by Application (2019-2024)

Table 32. Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Injectable Anthelmintic Drugs Revenue Share by Application (2025-2030)

Table 34. North America Injectable Anthelmintic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Injectable Anthelmintic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Injectable Anthelmintic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Injectable Anthelmintic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Injectable Anthelmintic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Injectable Anthelmintic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Injectable Anthelmintic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Injectable Anthelmintic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Injectable Anthelmintic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Injectable Anthelmintic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Injectable Anthelmintic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Injectable Anthelmintic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Injectable Anthelmintic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Injectable Anthelmintic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Injectable Anthelmintic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Injectable Anthelmintic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Injectable Anthelmintic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Injectable Anthelmintic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Injectable Anthelmintic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Injectable Anthelmintic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Injectable Anthelmintic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Injectable Anthelmintic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Injectable Anthelmintic Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Injectable Anthelmintic Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Injectable Anthelmintic Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Injectable Anthelmintic Drugs Product

Table 69. Novartis Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)

Table 70. Novartis Recent Developments

Table 71. Cipla Company Details

Table 72. Cipla Business Overview

Table 73. Cipla Injectable Anthelmintic Drugs Product

Table 74. Cipla Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)

Table 75. Cipla Recent Developments

Table 76. Sun Pharmaceutical Industries Company Details

Table 77. Sun Pharmaceutical Industries Business Overview

Table 78. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product

Table 79. Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)

Table 80. Sun Pharmaceutical Industries Recent Developments

Table 81. Amneal Pharmaceuticals Company Details

Table 82. Amneal Pharmaceuticals Business Overview

Table 83. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product

Table 84. Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)

Table 85. Amneal Pharmaceuticals Recent Developments

Table 86. Zoetis Company Details

Table 87. Zoetis Business Overview

Table 88. Zoetis Injectable Anthelmintic Drugs Product

Table 89. Zoetis Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)

Table 90. Zoetis Recent Developments

Table 91. GlaxoSmithKline Company Details

Table 92. GlaxoSmithKline Business Overview

Table 93. GlaxoSmithKline Injectable Anthelmintic Drugs Product

Table 94. GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)

Table 95. GlaxoSmithKline Recent Developments

Table 96. Bayer Company Details

Table 97. Bayer Business Overview

Table 98. Bayer Injectable Anthelmintic Drugs Product

Table 99. Bayer Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)

Table 100. Bayer Recent Developments

Table 101. Merck Company Details

Table 102. Merck Business Overview

Table 103. Merck Injectable Anthelmintic Drugs Product

Table 104. Merck Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)

Table 105. Merck Recent Developments

Table 106. Boehringer Ingelheim International Company Details

Table 107. Boehringer Ingelheim International Business Overview

Table 108. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product

Table 109. Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2019-2024) & (US$ Million)

Table 110. Boehringer Ingelheim International Recent Developments

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Injectable Anthelmintic Drugs Market Share by Type: 2023 VS 2030

Figure 3. Benzimidazoles Features

Figure 4. Piperazine Features

Figure 5. Imidazothiazole Features

Figure 6. Spiroindoles Features

Figure 7. Others Features

Figure 8. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Injectable Anthelmintic Drugs Market Share by Application: 2023 VS 2030

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Veterinary Pharmacies Case Studies

Figure 14. Others Case Studies

Figure 15. Injectable Anthelmintic Drugs Report Years Considered

Figure 16. Global Injectable Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Injectable Anthelmintic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Injectable Anthelmintic Drugs Market Share by Region: 2023 VS 2030

Figure 19. Global Injectable Anthelmintic Drugs Market Share by Players in 2023

Figure 20. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2023

Figure 22. North America Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

Figure 24. North America Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

Figure 25. North America Injectable Anthelmintic Drugs Market Share by Country (2019-2030)

Figure 26. United States Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Injectable Anthelmintic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 29. Europe Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

Figure 30. Europe Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

Figure 31. Europe Injectable Anthelmintic Drugs Market Share by Country (2019-2030)

Figure 32. Germany Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. China Injectable Anthelmintic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 39. China Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

Figure 40. China Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

Figure 41. Asia Injectable Anthelmintic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 42. Asia Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

Figure 43. Asia Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

Figure 44. Asia Injectable Anthelmintic Drugs Market Share by Region (2019-2030)

Figure 45. Japan Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. South Korea Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. China Taiwan Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. India Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Australia Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Type (2019-2030)

Figure 53. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Application (2019-2030)

Figure 54. Middle East, Africa, and Latin America Injectable Anthelmintic Drugs Market Share by Country (2019-2030)

Figure 55. Brazil Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Mexico Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Turkey Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Israel Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. GCC Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. Novartis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)

Figure 62. Cipla Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)

Figure 63. Sun Pharmaceutical Industries Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)

Figure 64. Amneal Pharmaceuticals Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)

Figure 65. Zoetis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)

Figure 66. GlaxoSmithKline Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)

Figure 67. Bayer Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)

Figure 68. Merck Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)

Figure 69. Boehringer Ingelheim International Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions